Molecular Templates, Inc. (MTEM): Price and Financial Metrics
MTEM Price/Volume Stats
Current price | $0.16 | 52-week high | $4.12 |
Prev. close | $0.35 | 52-week low | $0.14 |
Day low | $0.14 | Volume | 8,751,500 |
Day high | $0.18 | Avg. volume | 3,873,544 |
50-day MA | $0.46 | Dividend yield | N/A |
200-day MA | $1.26 | Market Cap | 1.05M |
MTEM Stock Price Chart Interactive Chart >
Molecular Templates, Inc. (MTEM) Company Bio
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies for the treatment of cancer and other serious diseases. It develops MT-3724, a lead drug candidate that is in a Phase 1 clinical trial in heavily pre-treated non-Hodgkin's lymphoma patients; MT-4019, a preclinical drug candidate targeting CD38; and evofosfamide, an investigational hypoxia-activated prodrug of a bis-alkylating agent that is preferentially activated under severe hypoxic tumor conditions, a feature of many solid tumors. The company is based in Austin, Texas.
MTEM Price Returns
1-mo | -57.89% |
3-mo | -88.15% |
6-mo | -84.62% |
1-year | -95.70% |
3-year | -99.72% |
5-year | -99.92% |
YTD | -95.71% |
2023 | -24.19% |
2022 | -91.63% |
2021 | -58.25% |
2020 | -32.86% |
2019 | 246.16% |
Continue Researching MTEM
Want to see what other sources are saying about Molecular Templates Inc's financials and stock price? Try the links below:Molecular Templates Inc (MTEM) Stock Price | Nasdaq
Molecular Templates Inc (MTEM) Stock Quote, History and News - Yahoo Finance
Molecular Templates Inc (MTEM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...